GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
₹2,919.80
arrow_downward
-0.29%(-8.40) 1D
Sep 9, 3:30:00 PM GMT+5:30 · INR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLAXO...
Open
₹2,928.20
High
₹2,959.60
Low
₹2,875.00
Mkt. cap
494.63B
Avg. vol.
0.00
Volume
29.12K
Dividend
1.95%
Quarterly dividend
₹14.25
Ex-dividend date
May 29, 2026
P/E ratio
46.31
52-wk high
₹3,120.70
52-wk low
₹2,088.10
EPS
₹63.05
Shares outstanding
169.41M
No. of employees
3K
Open
₹2,928.20
High
₹2,959.60
Low
₹2,875.00
Mkt. cap
494.63B
Avg. vol.
0.00
Volume
29.12K
Dividend
1.95%
Quarterly dividend
₹14.25
Ex-dividend date
May 29, 2026
P/E ratio
46.31
52-wk high
₹3,120.70
52-wk low
₹2,088.10
EPS
₹63.05
Shares outstanding
169.41M
No. of employees
3K
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd
CEO-
Employees3.1K
FoundedNov 13, 1924
Headquarters-
SectorPharmaceutical industry
Websiteindia-pharma.gsk.com